Clinical Trial Update: Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 study of ARO-C3 from Arrowhead Pharmaceuticals in adults, including healthy volunteers and patients with com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy
• Iga Nephropathy

Drugs mentioned

• ARO-C3

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: C3 Glomerulopathy, IgA Nephropathy | Phase 1, Phase 2 | Status: COMPLETED